The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche/Genentech; Takeda
Speakers' Bureau - Roche/Genentech
Research Funding - AstraZeneca Spain
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
 
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; MSD; Roche
First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA.
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Tudor-Eliade Ciuleanu
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Ipsen; Janssen; MSD; Pfizer; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Ipsen; Janssen; MSD; Pfizer; Roche; Sanofi; SERVIER
 
Manuel Cobo
No Relationships to Disclose
 
Michael Schenker
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer/EMD Serono; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol Myers Squibb
 
Bogdan Zurawski
No Relationships to Disclose
 
Juliana Janoski de Menezes
No Relationships to Disclose
 
Eduardo Richardet
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche; SERVIER
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Genzyme; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; Novartis; PeerVoice; Pfizer; Prime Oncology; Roche; Springer; Takeda; touchIME
Research Funding - EMD Serono (Inst); Merck (Inst)
Other Relationship - GRÍFOLS
 
Oscar Juan-Vidal
No Relationships to Disclose
 
Aurella Alexandru
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Sandoz
Expert Testimony - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Sanofi
 
Hiroshi Sakai
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Merck KGaA; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical
 
Arnaud Scherpereel
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; Menarini; Pfizer; PrIME Oncology; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca; BMS; Hansoh; HenRui; Hutchison MediPharma; Roche
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck Serono; Mirati Therapeutics; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; GlaxoSmithKline; Helsinn Therapeutics; Incyte; Inivata; Inovio Pharmaceuticals; Janssen; Kyowa Hakko Kirin; Loxo; Merck; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb
 
Arteid Memaj
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sathiya Marimuthu
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Hutchison MediPharma (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Hutchison MediPharma (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb (I)
 
Phuong Tran
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Tom John
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Ignyta; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Roche